Jaya Surgical And Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.25 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.45 Cr
as on 16-11-2024
- Revenue 2.29%
(FY 2023)
- Profit 1.57%
(FY 2023)
- Ebitda 2.56%
(FY 2023)
- Net Worth 12.87%
(FY 2023)
- Total Assets 66.95%
(FY 2023)
About Jaya Surgical And Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹8.25 Cr. The company has closed loans amounting to ₹4.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhu Ramadugu, Gorukanti Lakshmi, Gorukanti Lakshmi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC048977
- Company No.
048977
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jaya Surgical And Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Ramadugu  | Managing Director | 01-Feb-2006 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gorukanti Lakshmi | Director | 01-Feb-2006 | Current |
| Gorukanti Lakshmi | Director | 01-Feb-2006 | Current |
| Jayasree Gorukanti | Director | 01-Feb-2006 | Current |
Financial Performance of Jaya Surgical And Pharma.
Jaya Surgical And Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a slight improvement in profitability, with a 1.57% increase in profit. The company's net worth Soared by an impressive increase of 12.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaya Surgical And Pharma?
In 2023, Jaya Surgical And Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Hospitalis Supply Solutions Private LimitedActive 12 years 3 months
Madhu Ramadugu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Aug 2009 | ₹8.00 Cr | Open |
Andhra Bank Creation Date: 03 Apr 2006 | ₹2.50 M | Open |
Indian Overseas Bank Creation Date: 01 Aug 2008 | ₹4.45 Cr | Satisfied |
How Many Employees Work at Jaya Surgical And Pharma?
Unlock and access historical data on people associated with Jaya Surgical And Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaya Surgical And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaya Surgical And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
